PharmacyCodes



Bromocriptinum [Inn-Latin] en es it fr

Bromocriptinum [Inn-Latin] Brand names, Bromocriptinum [Inn-Latin] Analogs

Bromocriptinum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Bromocriptinum [Inn-Latin] Chemical_Formula

C32H40BrN5O5

Bromocriptinum [Inn-Latin] RX_link

http://www.rxlist.com/cgi/generic3/bromocriptine.htm

Bromocriptinum [Inn-Latin] fda sheet

Bromocriptinum [Inn-Latin] msds (material safety sheet)

Bromocriptinum [Inn-Latin] Synthesis Reference

No information avaliable

Bromocriptinum [Inn-Latin] Molecular Weight

654.595 g/mol

Bromocriptinum [Inn-Latin] Melting Point

No information avaliable

Bromocriptinum [Inn-Latin] H2O Solubility

No information avaliable

Bromocriptinum [Inn-Latin] State

Solid

Bromocriptinum [Inn-Latin] LogP

No information avaliable

Bromocriptinum [Inn-Latin] Dosage Forms

Capsule

Bromocriptinum [Inn-Latin] Indication

For treatment of idiopathic or postencephalitic Parkinson's disease, dysfunctions associated with hyperprolactinemia and in the treatment of acromegaly.

Bromocriptinum [Inn-Latin] Pharmacology

Bromocriptine is an ergoline derivitave dopamine agonist that is used in the treatment of amenorrhea, female infertility, abnormal discharge of breast milk, hypogonadism, Parkinson's disease, and acromegaly. Bromocriptine produces its therapeutic effect in the treatment of Parkinson's disease, a clinical condition characterized by a progressive deficiency in dopamine synthesis in the substantia nigra, by directly stimulating the dopamine receptors in the corpus striatum.

Bromocriptinum [Inn-Latin] Absorption

No information avaliable

Bromocriptinum [Inn-Latin] side effects and Toxicity

No information avaliable

Bromocriptinum [Inn-Latin] Patient Information

Bromocriptinum [Inn-Latin] Organisms Affected

Humans and other mammals